Elevance Health loses $375M bonus revenue as court upholds CMS's Medicare Advantage rating methodology. Read more here.

A federal judge in Texas struck down Elevance Health’s lawsuit that argued the government unfairly lowered its Medicare ...

A federal judge in Texas on Tuesday rejected Elevance Health’s challenge of the U.S. government's calculation for the health ...

UnitedHealthcare just confirmed it is under investigation by the Department of Justice for Medicare Advantage fraud. It’s not ...

Insurers plan to keep sacrificing MA growth for profitability next year, after second quarter results for Humana and CVS ...

With a low price-to-earnings multiple and a significant presence in Seth Klarman’s investment portfolio, Elevance Health, Inc ...

This article covers recent healthcare enforcement actions: an FCA lawsuit on kickbacks and discrimination, the DOJ’s largest 2025 health care fraud takedown and a court ruling clarifying EKRA’s scope, ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $395.81, a high estimate of $500.00, and a low estimate of $297.00. A negative shift in sentiment is evident ...

Elevance Health, Inc. (NYSE:ELV) is one of the Most Undervalued Long Term Stocks to Buy According to Hedge Funds. On July 25, ...

Northern Light Health says it is ending its contract with Anthem. Northern Light says it has been in negotiations with Anthem ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $200.0 to $570.0 for Elevance Health during the past quarter.